1/56
Key terms and concepts from Chapters 1-5 (Introduction to drug use through Drug Action) covered in the lecture notes, focusing on definitions and core ideas for exam preparation.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Tolerance
A state in which repeated exposure to a drug reduces its effects, requiring larger doses for the same effect.
Pharmacokinetic tolerance
Tolerance due to changes in drug metabolism or disposition that reduce the drug’s effect.
Pharmacodynamic tolerance
Tolerance resulting from changes in the nervous system, such as receptor down-regulation or changes in receptor sensitivity.
Behavioral tolerance
Tolerance developed through learning and adaptation to the drug’s effects, reducing impairment.
Withdrawal
A cluster of symptoms that occur when a dependent user stops taking a drug.
Dependence
A state in which drug use becomes frequent and stopping is difficult, often with withdrawal symptoms.
Drug misuse
Using drugs or chemicals in greater amounts or for longer than prescribed, or for non-medical reasons.
Drug abuse
Use that causes social, occupational, psychological, or physical problems.
Gateway substances
Early indicators of a pattern of future drug use; not necessarily causal for later drug use.
Correlate
A variable that is related to another variable; correlation does not imply causation.
Correlation
A relationship where two factors move together; does not prove one causes the other.
Antecedent
A factor that occurs before initiation of drug use and can help explain relationships, though not necessarily causal.
Gateway substances as antecedents
Substances that may signal a pattern of future drug use rather than directly causing it.
Incentive Salience
Craving or wanting; the motivational 'wanting' attributed to drug cues, often subconscious.
Negative Affect
Depression, anxiety, and negative thoughts that can influence drug use.
Executive Function
Self-control and long-term decision-making abilities that can affect drug use and relapse.
Neuron
Nerve cell that transmits information; about 85–100 billion in the brain; has dendrites, cell body, axon, and axon terminals.
Glia
these cells that provide support, nutrients, waste removal, myelin, and the blood-brain barrier; make up most brain cells. Provides firmenss and structure to the brain (and make up 90% of it)
Dendrites
Branch-like structures that receive signals from other neurons.
Cell body (soma)
Contains the nucleus; integrates and interprets signals.
Axon
Long projection that conducts electrical impulses to the axon terminals.
Axon terminals
end-tufts that release neurotransmitters into the synapse.
Synapse
The gap between neurons where neurotransmitters are released to transfer signals.
Neurotransmitters
Chemical messengers that transmit signals across the synapse; major ones include dopamine, serotonin, norepinephrine, GABA, and endogenous opioids.
Dopamine
Neurotransmitter involved in pleasure and reward; many drugs increase this neurotransmitter in the reward pathway.
Serotonin
Neurotransmitter involved in mood, sleep, and sexual desire; affected by MDMA and LSD.
Norepinephrine
Neurotransmitter involved in arousal and attention; part of the fight/flight response.
GABA
Primary inhibitory neurotransmitter; reduces neuronal activity; targeted by alcohol and benzodiazepines.
Endogenous opioids
Natural opioid peptides (endorphins) involved in analgesia and reward.
Blood-brain barrier
Protective barrier that restricts passage of many substances from blood into the brain.
Autonomic Nervous System
Regulates involuntary actions; contains sympathetic and parasympathetic branches.
Sympathetic nervous system
Fight-or-flight branch; increases arousal (e.g., heart rate via norepinephrine).
Parasympathetic nervous system
Rest-and-digest branch; promotes relaxation and energy conservation (acetylcholine).
Somatic Nervous System
Controls voluntary movements and conveys sensory information to the CNS.
Central Nervous System
Brain and spinal cord; integrates information, learning, memory, and coordinated activity.
Agonist
A drug that mimics a neurotransmitter and activates the receptor.
Antagonist
A drug that binds to a receptor but does not activate it, blocking the neurotransmitter.
Synthesis (neurotransmitter)
Production of a neurotransmitter from precursor molecules.
Storage (neurotransmitter)
Packaging of neurotransmitters into synaptic vesicles for release.
Release (neurotransmitter)
Release of neurotransmitters into the synapse in response to an action potential.
Reuptake
Reabsorption of neurotransmitters back into the presynaptic neuron.
Metabolism (neurotransmitter)
Enzymatic breakdown of neurotransmitters, reducing their activity.
Dose-Response Curve
Graph of the size of a response to the amount of drug administered; threshold is the first observable effect; ceiling is the maximum effect.
LD50
Lethal dose for 50% of subjects in a test; a standard measure of toxicity.
Routes of administration
Ways of taking drugs: inhalation (smoking), injection, intranasal (snorting), oral (ingestion), subcutaneous, transdermal, etc.
Naloxone
Opioid receptor antagonist used to reverse opioid overdose.
Safety margin
Difference between the dose that produces the desired effect and the dose that causes unacceptable adverse effects.
Enzyme induction
Increased production of drug-metabolizing enzymes, leading to faster drug metabolism and reduced effects.
Drug deactivation
Ways a drug can stop working: unchanged elimination, metabolic change, or antagonism (e.g., naloxone) reducing activity.
Double-blind
Study design in which neither participants nor researchers know who receives the drug versus placebo.
Placebo
An inert substance used as a control; expectancy effects can produce real perceived changes.
Specific effects
Pharmacological effects produced by the drug’s interaction with receptors.
Nonspecific effects
Effects arising from expectations, context, or placebo rather than the drug’s pharmacology.
Categories of drugs (stimulants, depressants, opioids, hallucinogens/psychedelics, psychotherapeutics)
Major broad classes used to categorize drugs by their primary effects on the CNS.
Cocaine
Stimulant derived from the coca plant; blocks reuptake of dopamine, norepinephrine, and serotonin; commonly used in powder or crack forms; short half-life (~1 hour).
Fastest to slowest ways to get high
Inhalation
Intravenous (injection)
Insufflation (snorting)
Intramuscular injection
Subcutaneous (placed on the skin)
Oral ingestion (eating)
Ataxia
Impaired coordination